Lipid Formulations Enhance Bioavailability of Juniperonic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioactive fatty acid supplements lack effective formulations that enhance their usefulness in treating specific diseases and conditions, with juniperonic acid not previously investigated as a dietary supplement.
Innovation Solution
Development of lipid compositions containing juniperonic acid, either alone or in combination with other bioactive fatty acids like eicosapentaenoic acid, docosahexaenoic acid, and sciadonic acid, formulated as free fatty acids, ethyl esters, or in triglycerides, diglycerides, and phospholipids to enhance absorption and bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If bioactive fatty acids are provided as free fatty acids, then absorption is improved, but stability deteriorates
Solution Approach 1:
The patent uses lipid carriers (triglycerides, diglycerides, monoglycerides, phospholipids) as intermediary substances to deliver bioactive fatty acids. These carriers protect the fatty acids from oxidation and degradation while facilitating their absorption through incorporation into chylomicrons during intestinal lipid metabolism, thus resolving the contradiction between stability and absorption.
2Reliability
If juniperonic acid is used as a dietary supplement, then treatment effectiveness for specific diseases is improved, but lack of formulation knowledge worsens the ability to optimize bioavailability
Solution Approach 1:
The patent systematically varies formulation parameters including the type of lipid carrier (triglyceride, diglyceride, monoglyceride, phospholipid), the ratio of juniperonic acid to other fatty acids, and the presence of antioxidants to optimize bioavailability and stability. This structured parameter optimization enables effective use of juniperonic acid despite its previous lack of investigation as a supplement.
Data Source
AI summary
Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions and methods related to the production and use of juniperonic acid alone or in combination with other bioactive fatty acids and lipids including, but not limited to, eicosapentaenoic acid, docosahexaenoic acid, sciadonic acid, conjugated linoleic acid, non-β-oxidizable fatty acid analogues such as tetradecylthioacetic acid, fish oil, olive oil, and pine nut oil.